Insmed Incorporated
INSM
$116.00
$12.1111.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 229.62% | 152.62% | 52.36% | 18.90% | 22.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 229.62% | 152.62% | 52.36% | 18.90% | 22.94% |
| Cost of Revenue | 122.86% | 69.09% | 38.71% | 33.92% | 21.89% |
| Gross Profit | 261.37% | 180.52% | 56.36% | 14.36% | 23.26% |
| SG&A Expenses | 67.58% | 49.10% | 56.71% | 45.22% | 58.48% |
| Depreciation & Amortization | 64.77% | 53.37% | 21.77% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.90% | 46.87% | 38.17% | 31.12% | 38.54% |
| Operating Income | 12.86% | -1.83% | -31.50% | -37.08% | -46.02% |
| Income Before Tax | 36.60% | -39.55% | -67.97% | -6.90% | -63.37% |
| Income Tax Expenses | 60.64% | 22.51% | 30.18% | 48.33% | 54.84% |
| Earnings from Continuing Operations | 36.25% | -39.46% | -67.79% | -7.01% | -63.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.25% | -39.46% | -67.79% | -7.01% | -63.33% |
| EBIT | 12.86% | -1.83% | -31.50% | -37.08% | -46.02% |
| EBITDA | 13.83% | -0.69% | -31.20% | -36.94% | -46.52% |
| EPS Basic | 46.49% | -16.86% | -37.66% | 12.55% | -34.07% |
| Normalized Basic EPS | 26.08% | 13.58% | -5.75% | -8.98% | -15.70% |
| EPS Diluted | 46.48% | -16.89% | -37.80% | 12.51% | -33.96% |
| Normalized Diluted EPS | 26.08% | 13.58% | -5.75% | -8.98% | -15.70% |
| Average Basic Shares Outstanding | 19.14% | 19.34% | 21.90% | 22.37% | 21.83% |
| Average Diluted Shares Outstanding | 19.14% | 19.34% | 21.90% | 22.37% | 21.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |